
BVS
USDBioventus Inc. Class A Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$7.440
Kõrge
$7.500
Madal
$7.320
Maht
0.52M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
493.6M
Tööstusharu
Meditsiiniseadmed
Riik
United States
Kauplemisstatistika
Keskmine maht
0.34M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Bioventus Reports Third Quarter Financial Results
Q3 reported revenue of $138.7 million was comparable to last year and organic* revenue advanced 8%Third quarter GAAP earnings of $0.05 per diluted share increased compared to the prior-year period loss of $0.08 per
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
DURHAM, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (NASDAQ:BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today announced that it will report financial results for
Seotud aktsiad
NATR
Nature's Sunshine Products Inc.
NAD
Nuveen Quality Municipal Income Fund
INSP
Inspire Medical Systems Inc.
AVO
Mission Produce Inc.
EMP
Entergy Mississippi LLC First Mortgage Bonds 4.90% Series Due October 1 2066
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.